News

In the spirit of World Antimicrobial Awareness Week, we’d like to share a summary of the findings from the “Implementation and Impact of Paediatric Antimicrobial Stewardship Programs: A Systematic Scoping…

Professor Irja Lutsar, a prominent and active member of the Penta network for many years, has been elected as Estonia’s Woman of the Year by the Business and Professional Women…

Louise Hill presented the findings of a NeoVanc sub-study at ESPID’s 2020 Virtual Meeting in late October. Below is a summary of the study and findings.

Europe’s project RESCEU sheds new light on the fight against the Respiratory Syncytial Virus (RSV) and its economic impact

Our completely revamped online training course PentaTr@ining 2020: ‘HIV & other Congenital Infections’ kicks off today!

November 2020

Penta is the lead of the Clinical Research Working Group for the newly launched Global Accelerator for Paediatric Formulations (GAP-f), a network led by the World Health Organisation.

The c4c project, co-coordinated by Penta together with Janssen, Bayer and the University of Liverpool, has had its first review, titled “European research networks to facilitate drug research in children”,

Authors: Elena Mozzo; Valentina Ortolan; Elena Badio; Federica Batterman; and Chiara Novello In October 2019, Penta began hosting HIV educational sessions in 5 high schools in Padova,

Now is the time to “Speak up for health worker safety!” Working in stressful environments makes health workers more prone to errors which can lead to patient harm.

The 13th September marks World Sepsis Day. Infectious diseases remains a leading cause of death for children.

Penta has been invited to run a one-day session at the Republican Hospital of Infectious Diseases, St Petersburg conference on ‘Actual problems of HIV Infection: Mother and Child’ on Tuesday…

The second trial in neonatal sepsis sponsored by Penta is now in its final stretch towards completion.

Through 6 distinctive sessions, the WSC Spotlight will give an overview of the global epidemiology and burden of sepsis and AMR, exploring innovative, novel, and cost-effective approaches for the prevention…

Last Patient Last Visit (LPLV) completed for the Penta 17 Strategy for Maintenance of HIV suppression with integrase inhibitor + darunavir/ritonavir in children (SMILE) trial.

Results from from the ongoing P1093 and ODYSSEY (PENTA20) studies, published in The Lancet HIV journal, show that children over 20kg in weight can safely take adult doses (50mg) of…

A correspondence by Malte Kohns at St George’s University London to The Lancet Infectious Disease Journal, focusing on the importance of international collaboration.

July 2020